JP6632551B2 - 注入ポンプのエラー表示 - Google Patents
注入ポンプのエラー表示 Download PDFInfo
- Publication number
- JP6632551B2 JP6632551B2 JP2016575803A JP2016575803A JP6632551B2 JP 6632551 B2 JP6632551 B2 JP 6632551B2 JP 2016575803 A JP2016575803 A JP 2016575803A JP 2016575803 A JP2016575803 A JP 2016575803A JP 6632551 B2 JP6632551 B2 JP 6632551B2
- Authority
- JP
- Japan
- Prior art keywords
- pump
- infusion pump
- infusion
- program
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001802 infusion Methods 0.000 title claims description 212
- 239000003814 drug Substances 0.000 claims description 225
- 229940079593 drug Drugs 0.000 claims description 208
- 230000009471 action Effects 0.000 claims description 51
- 230000004044 response Effects 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- 238000003860 storage Methods 0.000 claims description 5
- 238000001990 intravenous administration Methods 0.000 description 20
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 18
- 229960003638 dopamine Drugs 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000004891 communication Methods 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000005086 pumping Methods 0.000 description 5
- 238000004448 titration Methods 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- 239000002131 composite material Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003168 generic drug Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010013710 Drug interaction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- DYAHQFWOVKZOOW-UHFFFAOYSA-N Sarin Chemical compound CC(C)OP(C)(F)=O DYAHQFWOVKZOOW-UHFFFAOYSA-N 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940124675 anti-cancer drug Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYIPABRMGYNQKB-UHFFFAOYSA-N benzyl n-(5-phenyl-1,3-oxazol-2-yl)carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC(O1)=NC=C1C1=CC=CC=C1 ZYIPABRMGYNQKB-UHFFFAOYSA-N 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000002550 vasoactive agent Substances 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6063—Optical identification systems
- A61M2205/6072—Bar codes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Description
Claims (14)
- 注入ポンプによって実行される方法であって、
前記注入ポンプにおいて、自動プログラミング要求を受け取るステップであって、前記自動プログラミング要求が、IV薬品コンテナ情報、注入ポンプ情報、および注入プログラム設定を含む、ステップと、
前記注入ポンプにおいて、前記注入プログラム設定を薬品ライブラリ・プログラム設定と比較するステップであって、前記薬品ライブラリ・プログラム設定が、前記注入ポンプにおいて格納された薬品ライブラリ内に設けられる、ステップと、
前記注入ポンプにおいて、前記比較に基づいて、前記注入プログラム設定が前記薬品ライブラリ・プログラム設定と一致するかまたは一致しないかについて判定するステップと、
前記注入ポンプにおいて、前記注入プログラム設定が、前記薬品ライブラリ設定と一致しないと判定したことに基づいて、エラー・メッセージを生成するステップと、
前記注入ポンプにおいて画面を所定時間だけ表示するステップであって、前記画面が前記エラー・メッセージおよび提案行為を含む、ステップと、
前記注入ポンプにおいて、前記所定時間の後に入力が前記注入ポンプにおいて受け取られないとき、前記自動プログラミング要求を自動的に拒否するステップと、
を含む、方法。 - 請求項1記載の方法において、前記画面が更に、1つ以上の入力選択肢を含む、方法。
- 請求項1記載の方法において、前記エラー・メッセージが、前記自動プログラミング要求と共に、エラーの原因を記述する、方法。
- 請求項1記載の方法において、前記判定するステップが、前記注入ポンプにおいてのみ実行される、方法。
- 請求項1記載の方法であって、更に、前記エラー・メッセージに対する応答を受け取るステップを含み、前記応答が前記提案行為を含む、方法。
- 請求項1記載の方法において、前記所定時間が約15〜35秒である、方法。
- 装置であって、
メモリと、
プロセッサと、を含み、
前記プロセッサがコンピュータ実行可能プログラム命令を実行し、前記プロセッサに、
自動プログラミング要求を受け取らせ、前記自動プログラミング要求が、IV薬品コンテナ情報、注入ポンプ情報および注入プログラム設定を含み、
前記注入プログラム設定を薬品ライブラリ・プログラム設定と比較させ、前記薬品ライブラリ・プログラム設定が、前記注入ポンプにおいて格納された薬品ライブラリ内に提供され、
前記比較に基づいて、前記注入プログラム設定が前記薬品ライブラリ・プログラム設定と一致するかまたは一致しないかについて判定させ、
前記注入プログラム設定が、前記薬品ライブラリ設定と一致しないと判定したことに基づいて、エラー・メッセージを生成させ、
前記注入ポンプ上において所定時間だけ画面を表示させ、前記画面が前記エラー・メッセージおよび提案行為を含み、
更に、前記所定時間の後に入力が前記注入ポンプにおいて受け取られないとき、前記自動プログラミング要求を自動的に拒否させる、装置。 - 請求項7記載の装置において、前記画面が更に、1つ以上の入力選択肢を含む、装置。
- 請求項7記載の装置において、前記エラー・メッセージが、前記自動プログラミング要求と共に、エラーの原因を記述する、装置。
- 請求項7記載の装置において、前記判定が前記注入ポンプにおいてのみ実行される、装置。
- 請求項7記載の装置において、前記コンピュータ実行可能プログラム命令が更に、前記プロセッサに、前記エラー・メッセージに対する応答を受け取らせ、前記応答が前記提案行為を含む、装置。
- 請求項9記載の装置において、前記所定時間が約15〜35秒である、装置。
- コンピュータ実行可能プログラム命令が格納されている非一時的コンピュータ読み取り可能記憶媒体であって、前記コンピュータ実行可能プログラム命令がプロセッサによって実行されると、前記プロセッサに、
自動プログラミング要求を受け取らせ、前記自動プログラミング要求が、IV薬品コンテナ情報、注入ポンプ情報および注入プログラム設定を含み、
前記注入プログラム設定を薬品ライブラリ・プログラム設定と比較させ、前記薬品ライブラリ・プログラム設定が、前記注入ポンプにおいて格納された薬品ライブラリ内に設けられ、
前記比較に基づいて、前記注入プログラム設定が前記薬品ライブラリ・プログラム設定と一致するかまたは一致しないかについて判定させ、
前記注入プログラム設定が前記薬品ライブラリ設定と一致しないと判定したことに基づいて、エラー・メッセージを生成させ、
前記注入ポンプにおいて画面を所定時間だけ表示させ、前記画面が前記エラー・メッセージおよび提案行為を含み、
前記エラー・メッセージおよび前記提案行為に応答してコマンドを受け取らせ、
前記所定時間の後にコマンドが前記注入ポンプにおいて受け取られないとき、前記自動プログラミング要求を自動的に拒否させる、非一時的コンピュータ読み取り可能記憶媒体。 - 請求項13記載の非一時的コンピュータ読み取り可能記憶媒体において、前記コンピュータ実行可能プログラム命令が更に、前記プロセッサに、前記コマンドに応答して注入プログラムを開始させる、非一時的コンピュータ読み取り可能記憶媒体。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462019198P | 2014-06-30 | 2014-06-30 | |
US62/019,198 | 2014-06-30 | ||
US14/755,021 US20150379237A1 (en) | 2014-06-30 | 2015-06-30 | Infusion pump error display |
US14/755,021 | 2015-06-30 | ||
PCT/US2015/038633 WO2016004088A1 (en) | 2014-06-30 | 2015-06-30 | Infusion pump error display |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017519585A JP2017519585A (ja) | 2017-07-20 |
JP2017519585A5 JP2017519585A5 (ja) | 2018-07-05 |
JP6632551B2 true JP6632551B2 (ja) | 2020-01-22 |
Family
ID=54930830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016575803A Active JP6632551B2 (ja) | 2014-06-30 | 2015-06-30 | 注入ポンプのエラー表示 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20150379237A1 (ja) |
EP (1) | EP3160545B1 (ja) |
JP (1) | JP6632551B2 (ja) |
AU (2) | AU2015284181B2 (ja) |
CA (1) | CA2950942C (ja) |
CO (1) | CO2017000688A2 (ja) |
ES (1) | ES2969432T3 (ja) |
WO (1) | WO2016004088A1 (ja) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9123077B2 (en) | 2003-10-07 | 2015-09-01 | Hospira, Inc. | Medication management system |
US8065161B2 (en) | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
AU2007317669A1 (en) | 2006-10-16 | 2008-05-15 | Hospira, Inc. | System and method for comparing and utilizing activity information and configuration information from mulitple device management systems |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
US8271106B2 (en) | 2009-04-17 | 2012-09-18 | Hospira, Inc. | System and method for configuring a rule set for medical event management and responses |
CA2852271A1 (en) | 2011-10-21 | 2013-04-25 | Hospira, Inc. | Medical device update system |
WO2014138446A1 (en) | 2013-03-06 | 2014-09-12 | Hospira,Inc. | Medical device communication method |
US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US20150066531A1 (en) | 2013-08-30 | 2015-03-05 | James D. Jacobson | System and method of monitoring and managing a remote infusion regimen |
US9662436B2 (en) | 2013-09-20 | 2017-05-30 | Icu Medical, Inc. | Fail-safe drug infusion therapy system |
US10311972B2 (en) | 2013-11-11 | 2019-06-04 | Icu Medical, Inc. | Medical device system performance index |
JP2016537175A (ja) | 2013-11-19 | 2016-12-01 | ホスピーラ インコーポレイテッド | 注入ポンプ自動化システムおよび方法 |
CA2945647C (en) | 2014-04-30 | 2023-08-08 | Hospira, Inc. | Patient care system with conditional alarm forwarding |
US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
US9802495B2 (en) * | 2014-08-22 | 2017-10-31 | Ford Global Technologies, Llc | Off-board charger for high-voltage battery charging |
US9539383B2 (en) | 2014-09-15 | 2017-01-10 | Hospira, Inc. | System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein |
EP4400130A3 (en) | 2015-02-18 | 2024-10-16 | Insulet Corporation | Fluid delivery and infusion devices |
WO2016189417A1 (en) | 2015-05-26 | 2016-12-01 | Hospira, Inc. | Infusion pump system and method with multiple drug library editor source capability |
US20170061096A1 (en) * | 2015-08-31 | 2017-03-02 | Cerner Innovation, Inc. | Workflow driven barcode generation for infusion pumps |
US10130754B2 (en) * | 2015-11-12 | 2018-11-20 | Zyno Medical, Llc | Modular medical pump system |
EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
WO2017123703A2 (en) | 2016-01-14 | 2017-07-20 | Bigfoot Biomedical, Inc. | Occlusion resolution in medication delivery devices, systems, and methods |
EP3443998A1 (en) | 2016-01-14 | 2019-02-20 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
WO2017176928A1 (en) * | 2016-04-08 | 2017-10-12 | Icu Medical, Inc. | Control of a drug infusion device |
WO2018013842A1 (en) | 2016-07-14 | 2018-01-18 | Icu Medical, Inc. | Multi-communication path selection and security system for a medical device |
EP3515535A1 (en) | 2016-09-23 | 2019-07-31 | Insulet Corporation | Fluid delivery device with sensor |
CA3037432A1 (en) | 2016-12-12 | 2018-06-21 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and related systems and methods |
EP3568859A1 (en) | 2017-01-13 | 2019-11-20 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
US10881792B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
US20190336682A1 (en) * | 2018-05-02 | 2019-11-07 | Insulet Corporation | Code scanning for drug delivery |
AU2019263490A1 (en) | 2018-05-04 | 2020-11-26 | Insulet Corporation | Safety constraints for a control algorithm-based drug delivery system |
US10861592B2 (en) | 2018-07-17 | 2020-12-08 | Icu Medical, Inc. | Reducing infusion pump network congestion by staggering updates |
WO2020018389A1 (en) | 2018-07-17 | 2020-01-23 | Icu Medical, Inc. | Systems and methods for facilitating clinical messaging in a network environment |
NZ771914A (en) | 2018-07-17 | 2023-04-28 | Icu Medical Inc | Updating infusion pump drug libraries and operational software in a networked environment |
US10964428B2 (en) | 2018-07-17 | 2021-03-30 | Icu Medical, Inc. | Merging messages into cache and generating user interface using the cache |
CA3107315C (en) | 2018-07-26 | 2023-01-03 | Icu Medical, Inc. | Drug library management system |
US10692595B2 (en) | 2018-07-26 | 2020-06-23 | Icu Medical, Inc. | Drug library dynamic version management |
US11628251B2 (en) | 2018-09-28 | 2023-04-18 | Insulet Corporation | Activity mode for artificial pancreas system |
US11565039B2 (en) | 2018-10-11 | 2023-01-31 | Insulet Corporation | Event detection for drug delivery system |
USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
EP4069082B1 (en) | 2019-12-06 | 2024-06-05 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
JP7512395B2 (ja) | 2020-01-06 | 2024-07-08 | インスレット コーポレイション | 持続する残差に基づく食事および/または運動行為の予測 |
US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
CA3180218A1 (en) * | 2020-04-15 | 2021-10-21 | Carefusion 303, Inc. | Infusion pump administration system |
US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
US11481590B1 (en) * | 2020-08-17 | 2022-10-25 | Express Scripts Strategic Development, Inc. | Pill bottles with conductive ink and reading systems and methods |
US12115351B2 (en) | 2020-09-30 | 2024-10-15 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
JP2024507812A (ja) * | 2021-02-18 | 2024-02-21 | ケアフュージョン 303、インコーポレイテッド | 相互運用可能なポンプのスマートバーコードid |
US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
EP4409581A1 (en) | 2021-09-27 | 2024-08-07 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
WO2023219607A1 (en) * | 2022-05-10 | 2023-11-16 | Carefusion 303, Inc. | Remote scanning and validating of clinical order device configurations |
US12097355B2 (en) | 2023-01-06 | 2024-09-24 | Insulet Corporation | Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994008647A1 (en) * | 1992-10-15 | 1994-04-28 | The General Hospital Corporation | An infusion pump with an electronically loadable drug library |
US20040167804A1 (en) * | 2002-04-30 | 2004-08-26 | Simpson Thomas L.C. | Medical data communication notification and messaging system and method |
US7895053B2 (en) * | 2003-10-07 | 2011-02-22 | Hospira, Inc. | Medication management system |
US8065161B2 (en) * | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
US8518021B2 (en) * | 2004-05-27 | 2013-08-27 | Baxter International Inc. | Apparatus and method for therapeutic delivery of medication |
JP2008080036A (ja) * | 2006-09-29 | 2008-04-10 | Terumo Corp | 医療用ポンプ |
US8974439B2 (en) * | 2009-01-02 | 2015-03-10 | Asante Solutions, Inc. | Infusion pump system and methods |
-
2015
- 2015-06-30 ES ES15814101T patent/ES2969432T3/es active Active
- 2015-06-30 EP EP15814101.0A patent/EP3160545B1/en active Active
- 2015-06-30 WO PCT/US2015/038633 patent/WO2016004088A1/en active Application Filing
- 2015-06-30 US US14/755,021 patent/US20150379237A1/en not_active Abandoned
- 2015-06-30 CA CA2950942A patent/CA2950942C/en active Active
- 2015-06-30 JP JP2016575803A patent/JP6632551B2/ja active Active
- 2015-06-30 AU AU2015284181A patent/AU2015284181B2/en active Active
-
2017
- 2017-01-26 CO CONC2017/0000688A patent/CO2017000688A2/es unknown
-
2020
- 2020-07-17 AU AU2020205342A patent/AU2020205342B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3160545B1 (en) | 2023-11-01 |
AU2015284181A1 (en) | 2016-12-01 |
EP3160545A1 (en) | 2017-05-03 |
EP3160545A4 (en) | 2018-03-07 |
AU2020205342A1 (en) | 2020-08-06 |
WO2016004088A1 (en) | 2016-01-07 |
CA2950942C (en) | 2023-08-22 |
CA2950942A1 (en) | 2016-01-07 |
AU2020205342B2 (en) | 2022-03-03 |
JP2017519585A (ja) | 2017-07-20 |
US20150379237A1 (en) | 2015-12-31 |
AU2015284181B2 (en) | 2020-05-07 |
CO2017000688A2 (es) | 2017-06-30 |
ES2969432T3 (es) | 2024-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6632551B2 (ja) | 注入ポンプのエラー表示 | |
US11574721B2 (en) | Matching delayed infusion auto-programs with manually entered infusion programs | |
US8560345B2 (en) | Medication administration and management system and method | |
NZ746415A (en) | Matching delayed infusion auto-programs with manually entered infusion programs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20170510 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180523 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180523 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190306 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190408 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190708 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191121 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191210 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6632551 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |